Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.030 GeneticVariation disease BEFREE The frequency distribution of the ACE and AT1 receptor gene polymorphism and their possible relation regarding malignant ventricular arrhythmias in patients with coronary artery disease (CAD) and left ventricular dysfunction was determined. 10615414 1999
Entrez Id: 472
Gene Symbol: ATM
ATM
0.010 GeneticVariation disease BEFREE The frequency distribution of the ACE and AT1 receptor gene polymorphism and their possible relation regarding malignant ventricular arrhythmias in patients with coronary artery disease (CAD) and left ventricular dysfunction was determined. 10615414 1999
Entrez Id: 9197
Gene Symbol: SLC33A1
SLC33A1
0.010 GeneticVariation disease BEFREE The frequency distribution of the ACE and AT1 receptor gene polymorphism and their possible relation regarding malignant ventricular arrhythmias in patients with coronary artery disease (CAD) and left ventricular dysfunction was determined. 10615414 1999
Entrez Id: 101054525
Gene Symbol: PGR-AS1
PGR-AS1
0.010 GeneticVariation disease BEFREE The frequency distribution of the ACE and AT1 receptor gene polymorphism and their possible relation regarding malignant ventricular arrhythmias in patients with coronary artery disease (CAD) and left ventricular dysfunction was determined. 10615414 1999
Entrez Id: 3107
Gene Symbol: HLA-C
HLA-C
0.010 GeneticVariation disease BEFREE These findings suggest that (1) patients with HCM caused by beta-MHC gene mutations exhibit labile repolarization quantified by QT variability analysis and, hence, may be more at risk for sudden death from ventricular arrhythmias, and (2) indices of QT variability may be particularly abnormal in patients with beta-MHC gene mutations that are associated with a poor prognosis. 10725281 2000
Entrez Id: 6331
Gene Symbol: SCN5A
SCN5A
0.100 GeneticVariation disease BEFREE Mutations in SCN5A, encoding the cardiac sodium (Na) channel, are linked to a form of the congenital long-QT syndrome (LQT3) that provokes lethal ventricular arrhythmias. 10772658 2000
Entrez Id: 3757
Gene Symbol: KCNH2
KCNH2
0.100 GeneticVariation disease BEFREE This review summarizes current findings about mutations causing LQT2, the mechanisms by which mutations may cause the clinical phenotype of a reduction in I(Kr) and a prolonged QT interval, and how this may be involved in the generation of ventricular arrhythmias. 11196567 2000
Entrez Id: 3753
Gene Symbol: KCNE1
KCNE1
0.050 Biomarker disease BEFREE These results, which show that KCNE1 and I(Ks) are involved in K(+) homeostasis, might have important implications for patients with I(Ks)-related long QT syndrome, because hypokalemia is a well known risk factor for the occurrence of torsades de pointes ventricular arrhythmia. 11438691 2001
Entrez Id: 6331
Gene Symbol: SCN5A
SCN5A
0.100 Biomarker disease BEFREE Here we report that mice heterozygous for a knock-in KPQ-deletion (SCN5A(Delta/+)) show the essential LQT3 features and spontaneously develop life-threatening polymorphous ventricular arrhythmias. 11533705 2001
Entrez Id: 3784
Gene Symbol: KCNQ1
KCNQ1
0.200 Biomarker disease BEFREE Mutations in the human minK gene KCNE1 have been linked to autosomal dominant and autosomal recessive long-QT (LQT) syndrome, a cardiac condition predisposing to ventricular arrhythmias. minK and KvLQT1, the LQT1 gene product, form a native cardiac K+ channel that regulates the slowly delayed rectifier potassium current I(Ks). 11692163 2001
Entrez Id: 3753
Gene Symbol: KCNE1
KCNE1
0.050 GeneticVariation disease BEFREE Mutations in the human minK gene KCNE1 have been linked to autosomal dominant and autosomal recessive long-QT (LQT) syndrome, a cardiac condition predisposing to ventricular arrhythmias. minK and KvLQT1, the LQT1 gene product, form a native cardiac K+ channel that regulates the slowly delayed rectifier potassium current I(Ks). 11692163 2001
Entrez Id: 6262
Gene Symbol: RYR2
RYR2
0.200 Biomarker disease BEFREE RyR2 mutations in patients with catecholaminergic induced sudden cardiac death provide further evidence linking the sympathetic nervous system, RyR2 and ventricular arrhythmias (2-4). 11897558 2002
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.040 GeneticVariation disease BEFREE The aim of this pilot study was to investigate the frequency distribution of a common polymorphism of the endothelin (ET-1) gene and its possible relation to the hemodynamic consequences of malignant ventricular arrhythmia in patients with structural heart disease. 12011762 2002
Entrez Id: 6262
Gene Symbol: RYR2
RYR2
0.200 Biomarker disease BEFREE In particular, the finding of mutations in the gene coding for cardiac ryanodine receptor (hRYR2), both in patients affected with ARVD2 and in patients affected with catecholaminergic ventricular arrhythmias or with familial ventricular tachyarrhythmia, is discussed. 12015469 2002
Entrez Id: 424
Gene Symbol: ARVD3
ARVD3
0.010 Biomarker disease BEFREE In particular, the finding of mutations in the gene coding for cardiac ryanodine receptor (hRYR2), both in patients affected with ARVD2 and in patients affected with catecholaminergic ventricular arrhythmias or with familial ventricular tachyarrhythmia, is discussed. 12015469 2002
Entrez Id: 3759
Gene Symbol: KCNJ2
KCNJ2
0.100 GeneticVariation disease BEFREE Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. 12045162 2002
Entrez Id: 6331
Gene Symbol: SCN5A
SCN5A
0.100 GeneticVariation disease BEFREE These three new SCN5A mutations in Brugada syndrome patients are all located within domain I of SCN5A, a region not previously considered important in the development of ventricular arrhythmias. 12051963 2002
Entrez Id: 2697
Gene Symbol: GJA1
GJA1
0.100 Biomarker disease BEFREE While the Cx43 CKO mice have normal heart structure and contractile function, they die suddenly from spontaneous ventricular arrhythmias. 12064616 2001
Entrez Id: 3759
Gene Symbol: KCNJ2
KCNJ2
0.100 GeneticVariation disease BEFREE Evaluation of candidate loci culminated in the identification of a heterozygous missense mutation (R67W) in KCNJ2, the gene encoding the inward-rectifying potassium current, Kir2.1, in 41 members of a kindred in which ventricular arrhythmias (13 of 16 female members [81%]) and periodic paralysis (10 of 25 male members [40%]) segregated as autosomal dominant traits with sex-specific variable expressivity. 12148092 2002
Entrez Id: 3759
Gene Symbol: KCNJ2
KCNJ2
0.100 GeneticVariation disease BEFREE LQT was the primary cardiac manifestation, present in 71% of KCNJ2 mutation carriers, with ventricular arrhythmias present in 64%. 12163457 2002
Entrez Id: 6262
Gene Symbol: RYR2
RYR2
0.200 GeneticVariation disease BEFREE Mutations in the human cardiac Ca2+ release channel (ryanodine receptor, RyR2) gene have recently been shown to cause effort-induced ventricular arrhythmias. 12169647 2002
Entrez Id: 2697
Gene Symbol: GJA1
GJA1
0.100 Biomarker disease BEFREE Heterogeneous reduction of Cx43 protein may result in development of malignant ventricular arrhythmia in DCM. 12380923 2002
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.010 GeneticVariation disease BEFREE Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia. 12421483 2002
Entrez Id: 3757
Gene Symbol: KCNH2
KCNH2
0.100 GeneticVariation disease BEFREE Mutations in the potassium channel encoded by the human ether-a-go-go-related gene (HERG) have been linked to the congenital long QT syndrome (LQTS), a cardiac disease associated with an increased preponderance of ventricular arrhythmias and sudden death. 12885765 2003
Entrez Id: 6262
Gene Symbol: RYR2
RYR2
0.200 GeneticVariation disease BEFREE Mutant RyR2, found in patients with catecholaminergic polymorphic ventricular tachycardia, has decreased calstabin2 binding affinity, which can trigger ventricular arrhythmias and sudden cardiac death after stress and exercise. 14659699 2003